Shanghai Haohai Biological Technology Co., Ltd. announced that according to the requirement that an independent director, in principle, may act as independent director for a maximum of three domestic listed companies under the Measures for the Administration of Independent Directors of Listed Companies promulgated by the China Securities Regulatory Commission on 1 August 2023, in order to fulfill the regulatory requirement as well as considering the personal efforts dedicated to perform his work, Mr. Guo Yongqing has tendered his resignation as an independent non-executive director (INED) of the Fifth Session of the Board and all positions held by him in the special committees under the Board (that is chairman of the Audit Committee, member of the Remuneration and Appraisal Committee and member of the Nomination Committee). The resignation of Mr. Guo Yongqing shall take effect upon the passing of the resolution of election of the new INED at the general meeting.